Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomatrik is a China-based life science materials and reagent company focused on PEG-based biochemical reagents, PEG modifiers, bioconjugation reagents, biodegradable polymers, and related custom services. The company appears to serve research and preclinical customers rather than operate a therapeutic drug pipeline. Its offerings are used across bioengineering, biotechnology, drug discovery, and laboratory research, and public materials also describe capabilities in custom synthesis and biomaterial development. Biomatrik markets products such as PEG derivatives, linkers, biotin reagents, and biodegradable polymer materials, positioning itself as an enabling supplier to academic and industrial research users.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomatrik.